ANDA 71785, held by Chartwell Molecules. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 71785 (Clonidine Hydrochloride), held by Chartwell Molecules, was first approved by FDA on Apr 5, 1988, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 5, 1988 | Original application | Approved | None posted |
| Clonidine Hydrochloride0.3MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Clonidine Hydrochloride0.1MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Clonidine Hydrochloride0.2MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Jun 8, 2017 | Supplement 19Labeling · Standard review | Approved | None posted |
| Oct 5, 2006 | Supplement 13Labeling | Approved | None posted |
| Sep 18, 2000 | Supplement 11Manufacturing | Approved | None posted |
| May 18, 1998 | Supplement 10Manufacturing | Approved | None posted |
| Feb 18, 1997 | Supplement 9Labeling | Approved | None posted |
| Nov 13, 1996 | Supplement 8Manufacturing | Approved | None posted |
| Jul 26, 1994 | Supplement 7Manufacturing | Approved | None posted |
| Jan 3, 1990 | Supplement 6Labeling | Approved | None posted |
| Oct 18, 1989 | Supplement 5Labeling | Approved | None posted |
| May 12, 1988 | Supplement 1Manufacturing | Approved | None posted |
| May 12, 1988 | Supplement 2Labeling | Approved | None posted |
| Apr 5, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters